Shanghai pharmaceutical developer founded in 2016 working on global drug delivery systems - liposomes, nanocrystals, peptides and lipid nanoparticles - across new chemical entities, 505(b)(2) products and complex generics, with laboratories in Shanghai and Shandong and bases in the United States, Canada, India, England and Australia.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen